General Information of This Metabolic Reaction (MR) (ID:
MR007074) |
Formula |
Reactant |
Dapoxetine Metabolite M1 |
Product |
Dapoxetine Metabolite M2 |
Reactant Info
|
Product Info
|
Metabolic Type
|
Oxidation
-
Hydrolyzationn
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Characterization of Phase I Hepatic Metabolites of Anti-Premature Ejaculation Drug Dapoxetine by UHPLC-ESI-Q-TOF
|
2 |
Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012 Oct;4(5):233-51.
|
3 |
Effects of Evodiamine on the Pharmacokinetics of Dapoxetine and Its Metabolite Desmethyl Dapoxetine in Rats
|
4 |
Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.